Methadone Analgesia in Cancer Pain Patients on Chronic Methadone Maintenance Therapy  Paolo L Manfredi, MD, Gilbert R Gonzales, Andrea L Cheville, Craig.

Slides:



Advertisements
Similar presentations
Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.
Advertisements

The Relationship Between Depression and Pain Language in Cancer and Chronic Non- Cancer Pain Patients  Thomas C. Sist, DDS, Gerard A. Florio, PhD, Marguerite.
Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
Chronic Pain Management in Older Adults: Special Considerations
Characterization of Abdominal Pain During Methylnaltrexone Treatment of Opioid- Induced Constipation in Advanced Illness: A Post Hoc Analysis of Two Clinical.
Neurotoxicity from Chronic Opioid Therapy After Successful Palliative Treatment for Painful Bone Metastases  Andrew Broadbent, BMedSc, MBChB, FRACP, FAChPM,
Winston C. -V. Parris, MD, Benjamin W. Johnson, MD, Marilyn K
Use of strong opioids in advanced cancer pain: a randomized trial
Insights Into the Reluctance of Patients With Late-Stage Cancer to Adopt Exercise as a Means to Reduce Their Symptoms and Improve Their Function  Andrea.
Wen Jing Chung, MD, MS, Gregory H. Pharo, DO 
Analysis and treatment of different types of neuropathic cancer pain
Improving Adherence to Cancer Treatment by Addressing Quality of Life in Patients With Advanced Gastrointestinal Cancers  Andrea L. Cheville, MD, MSCE,
Effects of High Dose Opioids and Sedatives on Survival in Terminally Ill Cancer Patients  Tatsuya Morita, MD, Junichi Tsunoda, MD, Satoshi Inoue, MD,
An Effective Treatment of Severe Complex Regional Pain Syndrome Type 1 in a Child Using High Doses of Intrathecal Ziconotide  Michael Stanton-Hicks, MD,
Chronic Pain Management in Older Adults: Special Considerations
A Case Series of Patients Using Medicinal Marihuana for Management of Chronic Pain Under the Canadian Marihuana Medical Access Regulations  Mary E. Lynch,
A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs  Charles E. Argoff,
Morphine-Methadone Opioid Rotation in Cancer Patients: Analysis of Dose Ratio Predicting Factors  Miguel Angel Benítez-Rosario, MD, PhD, Antonio Salinas-Martín,
Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief  Giovambattista Zeppetella, FRCP  Journal.
Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety  Meredith Noble, MS, Stephen J. Tregear,
Edmonton, Canada: A Regional Model of Palliative Care Development
Optimization of opioid therapy for preventing incident pain associated with bone metastases  Sebastiano Mercadante, MD, Patrizia Villari, MD, Patrizia.
Patient-Controlled Analgesia With Intravenous L-Methadone in a Child With Cancer Pain Refractory to High-Dose Morphine  Rainer Sabatowski, MD, Stefan.
Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid- Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched,
What Palliative Care-Related Problems Do Patients Experience at HIV Diagnosis? A Systematic Review of the Evidence  Victoria M. Simms, MSc, Irene J. Higginson,
Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients  Laura L Adams, PhD, Robert.
The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics.
Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
Symptomatic Therapy of Dyspnea with Strong Opioids and Its Effect on Ventilation in Palliative Care Patients  Katri Elina Clemens, MD, PhD, Eberhard Klaschik,
Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative.
Buprenorphine: Considerations for Pain Management
Safety and Effectiveness of Palliative Drug Treatment in the Last Days of Life—A Systematic Literature Review  Kristian Jansen, MD, Dagny F. Haugen, MD,
Isaac M. Bromberg, MD  Journal of Pain and Symptom Management 
Jean-Pierre Van Buyten, MD  Journal of Pain and Symptom Management 
Transdermal Fentanyl for Chronic Pain in AIDS
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
Redefining Appropriate Treatment Expectations
Characterization of the early pharmacodynamic profile of oral methadone for cancer- related breakthrough pain: a pilot study  Kim Fisher, PhD, Carla Stiles,
Subcutaneous Lymphatic Drainage (Lymphcentesis) for Palliation of Severe Refractory Lymphedema in Cancer Patients  Juliet Jacobsen, MD, DPH, Craig D.
Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD 
Suresh K Joishy, MD, FACP, Declan Walsh, MSc, FACP 
Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD 
Evaluation of Methadone Absorption After Topical Administration to Hospice Patients  Robert K. Sylvester, PharmD, Caroline Schauer, RN, John Thomas, MD,
Ecological Momentary Assessment of Fatigue in Patients Receiving Intensive Cancer Therapy  Eileen Danaher Hacker, PhD, APN, AOCN, Carol Estwing Ferrans,
Cancer patients' share in a population's Use of opioids
The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer  Jane T. Hickok, MD, MPH, Joseph A. Roscoe,
Chronic opioid therapy for non-cancer pain
Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD 
The Role of a Low-Dose Ketamine-Midazolam Regimen in the Management of Severe Painful Crisis in Patients With Sickle Cell Disease  Qutaiba A. Tawfic,
Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD 
Strategies in Pain Management
Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer.
Changing M3G/M6G Ratios and Pharmacodynamics in a Cancer Patient During Long- Term Morphine Treatment  Gertrud Andersen, MD, Lona L Christrup, PhD, Per.
Transdermal Fentanyl in Opioid-Naive Cancer Pain Patients
Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients?  Filipa Tavares, MD  Journal of Pain and Symptom.
The Impact of Delirium on the Circadian Distribution of Breakthrough Analgesia in Advanced Cancer Patients  Bruno Gagnon, MD, Peter G. Lawlor, MB, Isabelle.
Palliative Care Consultations
Long-Term Safety of Oral Transmucosal Fentanyl Citrate for Breakthrough Cancer Pain  Richard Payne, MD, Paul Coluzzi, MD, Lowell Hart, MD, Mary Simmonds,
The Asia Pacific Hospice Palliative Care Network
Physical Function in Patients with Cancer
Nina D. Wagner-Johnston, MD, Kathryn A. Carson, ScM, Stuart A
Gerd Inger Ringdal, PhD, Marit S Jordhøy, MD, Stein Kaasa, PhD 
Botucatu, Brazil: A Regional Community Palliative Care Model
Race and Residence: Intercounty Variation in Black-White Differences in Hospice Use  Kimberly S. Johnson, MD, MHS, Maragatha Kuchibhatla, PhD, Richard.
Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain  Deirdre M Neighbors, BA, Timothy J Bell,
Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety  Meredith Noble, MS, Stephen J. Tregear,
Patient-Controlled Analgesia for Children at Home
Gabapentin as an Adjuvant to Opioid Analgesia for Neuropathic Cancer Pain  Augusto Caraceni, MD, Ernesto Zecca, MD, Cinzia Martini, MD, Franco De Conno,
Opioid Equianalgesic Tables: Are They All Equally Dangerous?
Symptomatic Intravenous Antipyretic Therapy
Presentation transcript:

Methadone Analgesia in Cancer Pain Patients on Chronic Methadone Maintenance Therapy  Paolo L Manfredi, MD, Gilbert R Gonzales, Andrea L Cheville, Craig Kornick, MD, Richard Payne, MD  Journal of Pain and Symptom Management  Volume 21, Issue 2, Pages 169-174 (February 2001) DOI: 10.1016/S0885-3924(00)00252-9

Fig. 1 Patient 1 opioid doses, routes, and days of treatment (y-axis: pain intensity) Journal of Pain and Symptom Management 2001 21, 169-174DOI: (10.1016/S0885-3924(00)00252-9)

Fig. 2 Patient 2 opioid doses, routes, and days of treatment (y-axis: pain intensity) Journal of Pain and Symptom Management 2001 21, 169-174DOI: (10.1016/S0885-3924(00)00252-9)